Published in J Allergy Clin Immunol on January 01, 2010
Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immunol (2010) 2.62
Decision-making analysis for allergen immunotherapy versus nasal steroids in the treatment of nasal steroid-responsive allergic rhinitis. Am J Rhinol Allergy (2014) 1.98
The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol (2011) 1.81
Therapies for allergic inflammation: refining strategies to induce tolerance. Nat Med (2012) 1.75
Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J (2014) 1.74
The biodiversity hypothesis and allergic disease: world allergy organization position statement. World Allergy Organ J (2013) 1.32
Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy (2012) 1.06
EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy. Clin Transl Allergy (2012) 1.04
Immunology of IgG4-related disease. Clin Exp Immunol (2015) 1.00
Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses. Chest (2012) 0.88
Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy. Clin Transl Allergy (2012) 0.87
A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis. BMC Med (2014) 0.86
Clinical immunology review series: an approach to desensitization. Clin Exp Immunol (2010) 0.85
SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma. Allergy (2010) 0.85
Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper. World Allergy Organ J (2010) 0.85
Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure. Allergy (2014) 0.84
Induction of tolerance via the sublingual route: mechanisms and applications. Clin Dev Immunol (2011) 0.83
Subcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence? Am J Rhinol Allergy (2012) 0.82
Trends in Specific Immunotherapy for Allergic Rhinitis: A Survey of Chinese ENT Specialists. Allergy Asthma Immunol Res (2014) 0.81
Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany. Clin Transl Allergy (2015) 0.80
Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy. Health Qual Life Outcomes (2014) 0.79
IL-6 activated integrated BATF/IRF4 functions in lymphocytes are T-bet-independent and reversed by subcutaneous immunotherapy. Sci Rep (2013) 0.79
Tolerability of the SQ-standardised grass sublingual immunotherapy tablet in patients treated with concomitant allergy immunotherapy: a non-interventional observational study. Clin Transl Allergy (2016) 0.79
The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children. J Asthma Allergy (2011) 0.79
Peptide immunotherapy for childhood allergy - addressing translational challenges. Clin Transl Allergy (2011) 0.78
Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study. Clin Drug Investig (2016) 0.77
Protocol for a double-blind randomised controlled trial of low dose intradermal grass pollen immunotherapy versus a histamine control on symptoms and medication use in adults with seasonal allergic rhinitis (PollenLITE). Clin Transl Allergy (2013) 0.77
Safety and tolerability of an intra-seasonal initiation of the SQ-standardised grass allergy immunotherapy tablet: a non-interventional observational study investigating the feasibility during routine administration. Clin Drug Investig (2013) 0.77
Therapeutic effects and biomarkers in sublingual immunotherapy: a review. J Allergy (Cairo) (2012) 0.77
Is clinical tolerance possible after allergen immunotherapy? Curr Allergy Asthma Rep (2015) 0.76
Specific immunotherapy in grass pollen allergy. Hum Vaccin Immunother (2012) 0.76
New treatments for allergen immunotherapy. World Allergy Organ J (2014) 0.76
Specific immunotherapy by the sublingual route for respiratory allergy. Allergy Asthma Clin Immunol (2010) 0.76
Immunotherapy in all aspects. Eur Arch Otorhinolaryngol (2015) 0.76
Cost-effectiveness of grass pollen SCIT compared with SLIT and symptomatic treatment. Allergo J Int (2016) 0.75
Oral and sublingual immunotherapy. Curr Treat Options Allergy (2014) 0.75
Clinical management, expectations, and satisfaction of patients with moderate to severe allergic rhinoconjunctivitis treated with SQ-standardized grass-allergen tablet under routine clinical practice conditions in Spain. Clin Mol Allergy (2017) 0.75
Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis. Clinicoecon Outcomes Res (2012) 0.75
Protocol for a randomised, double-blind, placebo-controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomes. Clin Transl Allergy (2015) 0.75
Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol. Clin Transl Allergy (2015) 0.75
Physician's recommendation and explanation is important in the initiation and maintenance of allergen immunotherapy. Patient Prefer Adherence (2017) 0.75
Critical appraisal of Timothy grass pollen extract GRAZAX(®) in the management of allergic rhinitis. Drug Des Devel Ther (2015) 0.75
Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report. Ital J Pediatr (2017) 0.75
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients. Clin Transl Allergy (2013) 0.75
Role of immunotherapy in the treatment of allergic asthma. World J Clin Cases (2014) 0.75
[Costs of allergic diseases and saving potential by allergen-specific immunotherapy : A personal assessment]. HNO (2017) 0.75
Tiotropium Respimat inhaler and the risk of death in COPD. N Engl J Med (2013) 6.36
Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N Engl J Med (2014) 6.29
Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci U S A (2006) 5.96
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol (2004) 5.80
Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med (2012) 5.64
Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature (2002) 5.48
Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N Engl J Med (2003) 4.00
Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev (2002) 3.80
Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Curr Biol (2007) 3.55
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12
Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol (2006) 3.08
Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol Cell Proteomics (2006) 2.64
Interaction profiling identifies the human nuclear exosome targeting complex. Mol Cell (2011) 2.56
Identification of let-7-regulated oncofetal genes. Cancer Res (2008) 2.56
Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling. Cell (2012) 2.54
Retracted The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling. PLoS Biol (2006) 2.42
MSQuant, an open source platform for mass spectrometry-based quantitative proteomics. J Proteome Res (2010) 2.40
SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol (2012) 2.28
Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J Cell Biol (2011) 2.23
Serious skin toxicity with the combination of BRAF inhibitors and radiotherapy. J Clin Oncol (2013) 2.22
Microcolumns with self-assembled particle frits for proteomics. J Chromatogr A (2002) 2.17
Novel asymmetrically localizing components of human centrosomes identified by complementary proteomics methods. EMBO J (2011) 2.14
Delay in diagnosis of lung cancer in general practice. Br J Gen Pract (2006) 2.12
The human core exosome interacts with differentially localized processive RNases: hDIS3 and hDIS3L. EMBO J (2010) 2.07
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
Identification of miRNA targets with stable isotope labeling by amino acids in cell culture. Nucleic Acids Res (2006) 1.97
Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Chemother (2005) 1.94
A proteomic study of SUMO-2 target proteins. J Biol Chem (2004) 1.92
Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol (2006) 1.87
RGM is a repulsive guidance molecule for retinal axons. Nature (2002) 1.82
The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damage. J Cell Biol (2010) 1.82
The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. Mol Cell Proteomics (2008) 1.81
Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response. Mol Cell Proteomics (2010) 1.81
Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol (2006) 1.80
A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as a protein kinase A substrate. Mol Cell Proteomics (2002) 1.78
Allergic rhinitis. Lancet (2011) 1.74
NOPdb: Nucleolar Proteome Database. Nucleic Acids Res (2006) 1.68
The human cap-binding complex is functionally connected to the nuclear RNA exosome. Nat Struct Mol Biol (2013) 1.67
Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy (2009) 1.65
Detection of previously undiagnosed cases of COPD in a high-risk population identified in general practice. COPD (2012) 1.65
Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. J Allergy Clin Immunol (2008) 1.64
MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int J Cancer (2010) 1.62
Ordered organelle degradation during starvation-induced autophagy. Mol Cell Proteomics (2008) 1.61
A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics (2002) 1.61
Peak nasal inspiratory flow; normal range in adult population. Rhinology (2006) 1.60
Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes. Am J Surg Pathol (2007) 1.58
Beneficial effects of treatment with anti-IgE antibodies (Omalizumab) in a patient with severe asthma and negative skin-prick test results. Chest (2011) 1.53
Quantitative proteomics identifies ferritin in the innate immune response of C. elegans. Virulence (2011) 1.53
Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? Curr Med Res Opin (2009) 1.52
Pseudosubstrate regulation of the SCF(beta-TrCP) ubiquitin ligase by hnRNP-U. Genes Dev (2002) 1.51
Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study. J Allergy Clin Immunol (2002) 1.46
The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study. Laryngoscope (2009) 1.46
A mass spectrometry-friendly database for cSNP identification. Nat Methods (2007) 1.43
Comparison of classification systems in melanoma sentinel lymph nodes--an analysis of 697 patients from a single center. Cancer (2010) 1.42
The hand-foot-syndrome associated with medical tumor therapy - classification and management. J Dtsch Dermatol Ges (2010) 1.40
The Vtc proteins in vacuole fusion: coupling NSF activity to V(0) trans-complex formation. EMBO J (2002) 1.40
BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1. Mol Cell Biol (2004) 1.38
Identification of autophagosome-associated proteins and regulators by quantitative proteomic analysis and genetic screens. Mol Cell Proteomics (2012) 1.38
Quantitative proteomic assessment of very early cellular signaling events. Nat Biotechnol (2007) 1.35
Bacterial antibiotic resistance levels in Danish farmland as a result of treatment with pig manure slurry. Environ Int (2003) 1.32
Bioinformatic analysis of the nucleolus. Biochem J (2003) 1.30
Depletion of kinesin 5B affects lysosomal distribution and stability and induces peri-nuclear accumulation of autophagosomes in cancer cells. PLoS One (2009) 1.30
Urticaria and infections. Allergy Asthma Clin Immunol (2009) 1.28
Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol (2008) 1.28
FACT facilitates chromatin transcription by RNA polymerases I and III. EMBO J (2009) 1.23
Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. J Allergy Clin Immunol (2007) 1.22
Bod1, a novel kinetochore protein required for chromosome biorientation. J Cell Biol (2007) 1.22
Early detection of COPD in general practice. Int J Chron Obstruct Pulmon Dis (2011) 1.18
Different effects of CSA and CSB deficiency on sensitivity to oxidative DNA damage. Mol Cell Biol (2004) 1.17
The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationale. Respir Res (2013) 1.16
Advancing cell biology through proteomics in space and time (PROSPECTS). Mol Cell Proteomics (2012) 1.15
Chronic urticaria and infections. Curr Opin Allergy Clin Immunol (2004) 1.13
Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy--case report and review of the literature. Dermatology (2009) 1.12
Investigation of contact allergy to dental metals in 206 patients. Contact Dermatitis (2009) 1.10
Are meta-analysis-based comparisons solid evidence? J Allergy Clin Immunol (2013) 1.09
Inhibition of adipocyte differentiation by resistin-like molecule alpha. Biochemical characterization of its oligomeric nature. J Biol Chem (2002) 1.08
Atypical cutaneous herpes virus infection associated with fludarabine chemotherapy of lymphoma. Eur J Dermatol (2007) 1.07
The importance of considering safety data from large-scale clinical trials in patients with asthma. Chest (2015) 1.06
Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy. J Allergy Clin Immunol (2002) 1.06
IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis. Pediatr Allergy Immunol (2012) 1.04
EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy. Clin Transl Allergy (2012) 1.04
Temporal profiling of the chromatin proteome reveals system-wide responses to replication inhibition. Curr Biol (2008) 1.04
A wiring of the human nucleolus. Mol Cell (2006) 1.03